Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Retatrutide has delivered some of the most impressive outcomes seen in metabolic drug development
However, glutamine supplementation may be necessary in certain circumstances, such as high intensity or long-term workouts
Wegovy and Saxenda, both injectables, are the only GLP-1s FDA-approved for obesity
None of these ranges are validated clinical doses
Retatrutide is a triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, whereas semaglutide acts on GLP-1 receptors alone and tirzepatide targets both GIP and GLP-1 receptors
Most patients notice appetite reduction within 12 weeks
US$ 24.48
US$ 25.12
US$ 23.73
US$ 23.61
US$ 26.89
US$ 22.70
